Panbela Therapeutics ROCE
¿Qué es el ROCE de Panbela Therapeutics?
El ROCE de Panbela Therapeutics Inc. es -1,359.79%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con roce similar a Panbela Therapeutics
- Millennial Precious Metals Corp tiene ROCE de -1,485.19%
- Oragenics Inc tiene ROCE de -1,468.71%
- Hemp Naturals tiene ROCE de -1,452.04%
- Advantagewon Oil tiene ROCE de -1,446.04%
- Paringa Resources tiene ROCE de -1,393.41%
- Graycliff Exploration tiene ROCE de -1,374.81%
- Panbela Therapeutics tiene ROCE de -1,359.79%
- U.S. Lithium tiene ROCE de -1,313.60%
- Ucommune International Ltd tiene ROCE de -1,285.37%
- Kopin tiene ROCE de -1,279.14%
- 22nd Century Inc tiene ROCE de -1,242.47%
- Imagin Medical Inc tiene ROCE de -1,230.40%
- Aravive Inc tiene ROCE de -1,217.82%